Acute pulmonary embolism in COVID-19 related hypercoagulability.
Cerruti LorenzoBoscaro FrancescaPoletto FrancescoCampello ElenaSpiezia LucaSimioni PaoloPublished in: Journal of thrombosis and thrombolysis (2020)
Since December 2019, a novel Coronavirus (SARS-CoV-2) was confirmed as the etiologic agent of a worldwide outbreak of a pneumonia that can result in severe respiratory failure. This clinical entity seems to be associated with a marked hypercoagulable state that causes both arterial and venous thromboembolic complications. Therefore, an adequate anti-thrombotic prophylaxis is recommended in hospitalized COVID-19 patients. Although rapidly worsening respiratory symptoms in a patient with SARS-CoV-2 respiratory infection may correlate with worsening pneumonia itself, it may also mask a pulmonary embolism. We report the case of a 50-year-old man affected by SARS-CoV-2 pneumonia, who developed acute pulmonary embolism.
Keyphrases
- pulmonary embolism
- sars cov
- respiratory failure
- extracorporeal membrane oxygenation
- mechanical ventilation
- inferior vena cava
- respiratory syndrome coronavirus
- acute respiratory distress syndrome
- case report
- early onset
- risk factors
- atrial fibrillation
- coronavirus disease
- respiratory tract
- sleep quality
- hepatitis b virus